Sample size
| | | | |
| 0 – <16 (Children) | 1265 (41.9) | 1483 (43.62) | 0.1805 |
| ≥16 (Adults) | 1752 (58.1) | 1917 (56.38) | |
Age (Years)
| Mean ± SD | 19.71 ± 13.24 | 18.81 ± 12.52 | |
Gender, n(%)
| | | | |
| Female | 1423 (47,17) | 1578 (46.41) | 0.5623 |
| Male | 1594 (52.83) | 1822 (53.59) | |
Percent predicted FEV1, n(%)
| | | | |
| <40 | 333 (11.04) | 341 (10.03) | |
| 40–69 | 728 (24.13) | 846 (24.88) | |
| ≥70 | 1335 (44.25) | 1443 (42.44) | |
Age at diagnosis, n(%)
| | | | |
| <3 months; n (%) | 1280 (42.43) | 1590 (46.76) | <0.001 |
| 3–12 months; n (%) | 629 (20.85) | 645 (18.97) | |
| 12 months–3 years; n (%) | 416 (13.79) | 474 (13.94) | |
| ≥3 years; n (%) | 453 (15.01) | 488 (14.35) | |
FEV1 percent predicted
| | | | |
All patients
| Mean ± SD | 70.98 ± 24.66 | 71.23 ± 24.23 | 0.9821 |
Children (Age < 16)
| Mean ± SD | 84.51 ± 17.99 | 81.57 ± 19.80 | 0.0061 |
adults (Age ≥ 16)
| Mean ± SD | 64.69 ± 24.81 | 66.73 ± 24.61 | 0.0422 |